Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
 

_____ Brought to you by Thermo Fisher Scientific _____

A Customizable qPCR-based High Performance Assay Platform

REGISTER NOW

 

  November 13, 2018

  8:00 a.m. PST / 11:00 a.m. EST / 16:00 GMT / 17:00 CET

 

Overview

 

ProteinSEQ™, a qPCR-based ultra-high performance assay platform, enables easily customizable quantitative assays with high sensitivity, dynamic range, linearity, recovery, precision, and assay robustness. The system combines semi-automated magnetic bead-based protein antigen extraction with quantitative real-time PCR as readout. Its many advantages in assay workflow, robustness, and technical superiority make it an ideal assay platform system for ELISA replacement and streamlined bioprocessing. This study describes the use of customized ProteinSEQ assays in several quantitative applications in which the same ELISA capture/detection antibodies used on the ProteinSEQ platform resulted in orders of magnitude improvements in assay performance.

Brought to you by:

 

Key Learning Objectives

  • A rapid alternative for ELISA
  • A custom process-specific HCP and leached protein assay
  • A customized assay that provides order of magnitude improvement over ELISA

Who Should Attend

  • Lab Managers
  • Research Scientists
  • Core Facility Managers
  • Production/Process Engineers
  • Principal Investigators
  • Staff Scientists
  • Regulatory QA/QC
 

Speaker

Bharti Solanki, Ph. D.,
Scientist, Research & Development,
Pharma Analytics – Thermo Fisher Scientific
 

Moderator

Alex Taylor
Assistant Editor
C&EN
 

REGISTER NOW